Abstract
The trace detection of biomarkers in real samples has profound a most important significance in the early diagnosis and daily monitoring of diseases. Based on the ligand pre‐design strategy, a novel 3D CuMOF, with the formula of {[Cu4(BTPB)(μ2‐OH)2(H2O)5]·3H2O}n, was fabricated by using the hexacarboxyl ligand of 1,4‐bis(2,4,6‐tricarboxylpyrid‐5‐yl)benzene (H6BTPB) and tetranuclear {Cu4(COO)4(μ2‐OH)2} SBUs. Benefiting from the robust framework and unique luminescence performance, the prepared CuMOF displays great potential as a dual‐responsive efficient luminescent sensor in “turn‐off” detection of 3‐nitrotyrosine (3‐NT) biomarker and “turn‐on” detecting the anthrax biomarker of dipicolinic acid (DPA), with detection limits (LOD) for 3‐NT and DPA being 110.8 ng/ml and 85.2 ng/ml, respectively. Additionally, the practicality and compatibility of such developed sensors were verified by quantifying 3‐NT and DPA biomarkers in diluted serum and urine samples with satisfactory recoveries. Further, the theoretical calculations of energy levels as well as the spectral overlap between the analytes and CuMOF were conducted to elucidate the possible sensing mechanisms. This work demonstrated that MOFs‐based luminescent sensors are evolving as an efficacious and equable approach for the detection of biomarkers in real samples.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
